Also called as Fetal Retinoid Syndrome. Accutane Embryopathy is a characteristic pattern of mental and physical birth defects that results from maternal use of retinoids, the synthetic
vitamin A derivative during pregnancy. The most well known retinoid is
Isotretinoin (Accutane), a drug used to treat severe
nodular acne.
Signs and symptoms
The range and severity of associated birth abnormalities will vary greatly from case to case.
However, characteristic features may include growth delays before and after birth (prenatal and postnatal growth retardation), malformations of the skull and facial (craniofacial) region, central nervous system abnormalities, heart abnormalities.
Craniofacial defects
Facial asymmetry – Due to underdevelopment of the skull and facial bones
Cardiac anomalies
Others
Tests and diagnosis
History of Accutane use by the mother during the first trimester of pregnancy
Recognition of the gross physical abnormalities in an exposed infant
A prenatal ultrasound evaluation may detect abnormalities such as heart defects, hydrocephalus or microcephaly, or some craniofacial abnormalities.
Treatment and management
-
The care of an infant with Accutane embryopathy after delivery is primarily symptomatic.
-
Infants with serious heart abnormalities will need to be evaluated by cardiologists and may require surgery.
-
Infants with brain and nervous system abnormalities, such as hydrocephalus may require shunt placement soon after birth
-
Prognosis
-
Accutane is a safe and highly effective drug when used properly.
-
Accutane embryopathy is a serious medical condition that is directly related to a maternal use of Accutane during the first trimester of her pregnancy.
-
Although most individuals with Accutane embryopathy will have a normal lifespan, others may die at a young age due to complex internal abnormalities.
-
Mild or moderate mental handicap is common even when there are no obvious physical features of Accutane embryopathy.